Data / Form D filings / PhAST Corp.
PhAST Corp.: Form D filings
PhAST Corp., a biotechnology company in Boston, MA, filed 3 Form D notices with the SEC between 2021 and 2025. The latest, on April 24, 2025, reports $3.5 million sold of a $8 million offering to 5 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 38 WAREHAM STREET, FLOOR 2, Boston, MA, 02118
- Phone
- (617) 301-2014
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1887754
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 24, 2025 | New notice | $7,999,934 | $3,474,946 | $4,524,988 | 5 | Apr 11, 2025 | sec.gov |
| Dec 16, 2022 | New notice | $13,999,990 | $4,379,992 | $9,619,998 | 3 | Dec 2, 2022 | sec.gov |
| Oct 18, 2021 | New notice | $18,960,171 | $10,785,072 | $8,175,099 | 15 | Oct 4, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Roman Stocker | Executive Officer, Director | |
| Kwangmin Son | Executive Officer, Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Apr 21, 2025 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what PhAST Corp. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.